Hangzhou Youngpeptide Biotechnology HYB
Ordered peptides from Hangzhou Youngpeptide Biotechnology HYB? Mail in a sample (US only) and let us test it.
Test my supplyHangzhou Youngpeptide Biotechnology HYB's strongest evidence is GHK-Cu, with clean identity, high purity, and in-range fill across a modest run of tests despite missing batch IDs. Retatrutide and Tirzepatide are more dispersed: early purity misses, severe identity/quantity failures, and overfill are partly offset by later passes, but thin batch documentation
Corporate and channel records point to a Yura-centered HYB operation with a later Alex contact and no clean public registry anchor. The dossier maps storefront infrastructure, crypto and direct bank-transfer rails, Janoshik-claim gaps, and private-community routing.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Hangzhou Youngpeptide Biotechnology HYB rows.
Cancel anytime
Ordered peptides from Hangzhou Youngpeptide Biotechnology HYB? Mail in a sample (US only) and let us test it.
Test my supply| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
12 Aug 2026 | Pass | Tirzepatide Hangzhou Youngpeptide Biotechnology HYB | lab name | View COA | |||
20 Jul 2026 | Fail | Retatrutide Hangzhou Youngpeptide Biotechnology HYB | lab name | View COA | |||
28 Apr 2026 | Pass | Retatrutide Hangzhou Youngpeptide Biotechnology HYB | lab name | View COA | |||
6 Mar 2026 | Pass | Retatrutide Hangzhou Youngpeptide Biotechnology HYB | lab name | View COA | |||
15 Feb 2026 | Pass | BPC-157 Hangzhou Youngpeptide Biotechnology HYB | lab name | View COA | |||
11 Feb 2026 | Pass | GHK-Cu Hangzhou Youngpeptide Biotechnology HYB | lab name | View COA | |||
10 Feb 2026 | Pass | Retatrutide Hangzhou Youngpeptide Biotechnology HYB | lab name | View COA | |||
30 Dec 2025 | Pass | Retatrutide Hangzhou Youngpeptide Biotechnology HYB | lab name | View COA | |||
29 Dec 2025 | Pass | Tirzepatide Hangzhou Youngpeptide Biotechnology HYB | lab name | View COA | |||
29 Dec 2025 | Fail | Tirzepatide Hangzhou Youngpeptide Biotechnology HYB | lab name | View COA | |||
About Hangzhou Youngpeptide Biotechnology HYB test results from Finnrick
Hangzhou Youngpeptide Biotechnology HYB is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 4 peptides and 26 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Hangzhou Youngpeptide Biotechnology HYB peptides in this dataset are BPC-157 (3 tests), GHK-Cu (4 tests) and Retatrutide (10 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 26 recent tests.
Ordered peptides from Hangzhou Youngpeptide Biotechnology HYB? Mail in a sample (US only) and let us test it.
Test my supply